Literature DB >> 31227229

Th1/Th2/Th17/Treg Balance in Apical Periodontitis of Normoglycemic and Diabetic Rats.

Renata Oliveira Samuel1, Edilson Ervolino2, Índia Olinta de Azevedo Queiroz3, Mariane Maffei Azuma4, Gabriela Tiago Ferreira5, Luciano Tavares Angelo Cintra6.   

Abstract

INTRODUCTION: The aim of this study was to evaluate the inflammatory profile of T helper (Th) cells in normoglycemic (N) and diabetic rats with apical periodontitis (AP).
METHODS: Twenty male Wistar rats were divided in 2 groups: N rats and rats with diabetes mellitus (DM). DM was induced using streptozotocin, and AP was induced by dental pulp exposure of the first mandibular molar to the oral environment. After 30 days, the mandibles were removed and processed for histologic analysis, bacterial analysis, and immunochemical assays for interleukin (IL)-6, tumor necrosis factor alpha, IL-17, IL-23, interferon gamma, and IL-10. The Mann-Whitney U test and Student t test were used for statistical analysis (P < .05).
RESULTS: The DM group showed more intense inflammatory infiltrate with larger sizes of bone reabsorption and a greater presence of bacteria than the N group (P < .05). Proinflammatory cytokine levels in the DM group were also greater than those in the N group (P < .05). However, interferon gamma was more intense in the N group than in the DM group (P < .05).
CONCLUSIONS: The inflammatory profile of AP in DM is different from that in the N group, suggesting that Th1 is a secondary strain and the Th17 strain is predominant in DM.
Copyright © 2019 American Association of Endodontists. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apical periodontitis; diabetes mellitus; inflammation

Mesh:

Year:  2019        PMID: 31227229     DOI: 10.1016/j.joen.2019.05.003

Source DB:  PubMed          Journal:  J Endod        ISSN: 0099-2399            Impact factor:   4.171


  7 in total

Review 1.  Evolution of endodontic medicine: a critical narrative review of the interrelationship between endodontics and systemic pathological conditions.

Authors:  Luciano Tavares Angelo Cintra; Maximiliano Schünke Gomes; Cristiane Cantiga da Silva; Flávio Duarte Faria; Francine Benetti; Leopoldo Cosme-Silva; Renata Oliveira Samuel; Tiago Novaes Pinheiro; Carlos Estrela; Alvaro Cruz González; Juan José Segura-Egea
Journal:  Odontology       Date:  2021-07-08       Impact factor: 2.634

2.  Effect of type 2 diabetes mellitus on mandibular bone regeneration and the expression of T helper cell 17/regulat-ory T cell-related factors in mice.

Authors:  Ya Nan Wang; Xuan Wu; Ting Ting Jia; Yao Feng; Shi Yue Liu; Xin Xu; Dong Jiao Zhang
Journal:  Hua Xi Kou Qiang Yi Xue Za Zhi       Date:  2021-12-01

Review 3.  Clinical Translational Potentials of Stem Cell-Derived Extracellular Vesicles in Type 1 Diabetes.

Authors:  Wei Hu; Xiang Song; Haibo Yu; Jingyu Sun; Hongjun Wang; Yong Zhao
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-12       Impact factor: 5.555

Review 4.  Immune Dysregulation in IgG4-Related Disease.

Authors:  Jiachen Liu; Wei Yin; Lisa S Westerberg; Pamela Lee; Quan Gong; Yan Chen; Lingli Dong; Chaohong Liu
Journal:  Front Immunol       Date:  2021-09-01       Impact factor: 7.561

5.  Periapical and endodontic status of patients with inflammatory bowel disease: Age- and sex-matched case-control study.

Authors:  Juan J Segura-Sampedro; Carla Jiménez-Giménez; Enric Jane-Salas; Daniel Cabanillas-Balsera; Jenifer Martín-González; Juan J Segura-Egea; José López-López
Journal:  Int Endod J       Date:  2022-04-26       Impact factor: 5.165

Review 6.  T Cell Protein Tyrosine Phosphatase in Osteoimmunology.

Authors:  Ya-Nan Wang; Shiyue Liu; Tingting Jia; Yao Feng; Wenjing Zhang; Xin Xu; Dongjiao Zhang
Journal:  Front Immunol       Date:  2021-02-22       Impact factor: 7.561

7.  Type 2 diabetes and the clinically normal pulp: An in vitro study.

Authors:  Shaikhah Alsamahi; Trudy M Milne; Haizal Hussaini; Alison M Rich; Lara T Friedlander
Journal:  Int Endod J       Date:  2022-04-01       Impact factor: 5.165

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.